Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effects of Subanesthetic Ketamine Infusions on Motivation to Quit and Cue-Induced Craving in Cocaine-Dependent Research Volunteers
Elias Dakwar, Frances R. Levin, Richard W. Foltin, et al.
Biological Psychiatry (2013) Vol. 76, Iss. 1, pp. 40-46
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

The Nucleus Accumbens: Mechanisms of Addiction across Drug Classes Reflect the Importance of Glutamate Homeostasis
Michael D. Scofield, Jasper A. Heinsbroek, Cassandra D. Gipson, et al.
Pharmacological Reviews (2016) Vol. 68, Iss. 3, pp. 816-871
Open Access | Times Cited: 529
Ketamine and Rapid-Acting Antidepressants: A Window into a New Neurobiology for Mood Disorder Therapeutics
Chadi G. Abdallah, Gerard Sanacora, Ronald S. Duman, et al.
Annual Review of Medicine (2014) Vol. 66, Iss. 1, pp. 509-523
Open Access | Times Cited: 367
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos, Flávia de Lima Osório, José Alexandre S. Crippa, et al.
Therapeutic Advances in Psychopharmacology (2016) Vol. 6, Iss. 3, pp. 193-213
Open Access | Times Cited: 275
Ketamine abuse potential and use disorder
Yu Liu, Deyong Lin, Boliang Wu, et al.
Brain Research Bulletin (2016) Vol. 126, pp. 68-73
Open Access | Times Cited: 216
Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development
Eduardo Ekman Schenberg
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 191
Clinical applications of hallucinogens: A review.
Albert Garcia‐Romeu, Brennan Kersgaard, Peter H. Addy
Experimental and Clinical Psychopharmacology (2016) Vol. 24, Iss. 4, pp. 229-268
Open Access | Times Cited: 180
KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID‐ACTING ANTIDEPRESSANTS
Chadi G. Abdallah, Thomas G. Adams, Benjamin Kelmendi, et al.
Depression and Anxiety (2016) Vol. 33, Iss. 8, pp. 689-697
Open Access | Times Cited: 175
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
Antonio Inserra, Danilo De Gregorio, Gabriella Gobbi
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 202-277
Open Access | Times Cited: 164
Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review
Zach Walsh, Özden Merve Mollaahmetoğlu, Joseph M. Rootman, et al.
BJPsych Open (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 127
Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder
Meryem Grabski, Amy McAndrew, Will Lawn, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 152-162
Open Access | Times Cited: 104
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents
Christoph U. Correll, Marco Solmi, Samuele Cortese, et al.
World Psychiatry (2023) Vol. 22, Iss. 1, pp. 48-74
Open Access | Times Cited: 83
Ketamine in neuropsychiatric disorders: an update
Jenessa N. Johnston, Bashkim Kadriu, Christoph Kraus, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 1, pp. 23-40
Closed Access | Times Cited: 49
Psychedelics in the Treatment of Substance Use Disorders and Addictive Behaviors: A Scoping Review
Jérémie Richard, Albert Garcia‐Romeu
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access | Times Cited: 2
A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial
Elias Dakwar, Frances R. Levin, Carl L. Hart, et al.
American Journal of Psychiatry (2019) Vol. 177, Iss. 2, pp. 125-133
Open Access | Times Cited: 133
Glutamate Transporter GLT-1 as a Therapeutic Target for Substance Use Disorders
Douglas Roberts-Wolfe, Peter W. Kalivas
CNS & Neurological Disorders - Drug Targets (2015) Vol. 14, Iss. 6, pp. 745-756
Open Access | Times Cited: 131
Ketamine for the treatment of addiction: Evidence and potential mechanisms
Ivan Ezquerra-Romano, Will Lawn, Evgeny Krupitsky, et al.
Neuropharmacology (2018) Vol. 142, pp. 72-82
Open Access | Times Cited: 131
A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial
Elias Dakwar, Edward V. Nunes, Carl L. Hart, et al.
American Journal of Psychiatry (2019) Vol. 176, Iss. 11, pp. 923-930
Open Access | Times Cited: 128
Therapeutic infusions of ketamine: Do the psychoactive effects matter?
Elias Dakwar, C. Anerella, Carl L. Hart, et al.
Drug and Alcohol Dependence (2014) Vol. 136, pp. 153-157
Open Access | Times Cited: 108
Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review
Jennifer Jones, Camilo F. Mateus, Robert Malcolm, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 107
Ketamine applications beyond anesthesia – A literature review
Agata Nowacka, Małgorzata Borczyk
European Journal of Pharmacology (2019) Vol. 860, pp. 172547-172547
Closed Access | Times Cited: 103
Ketamine—50 years in use: from anesthesia to rapid antidepressant effects and neurobiological mechanisms
Samuel Kohtala
Pharmacological Reports (2021) Vol. 73, Iss. 2, pp. 323-345
Open Access | Times Cited: 93
Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature
Giovanni Martinotti, Stefania Chiappini, Mauro Pettorruso, et al.
Brain Sciences (2021) Vol. 11, Iss. 7, pp. 856-856
Open Access | Times Cited: 88
The Nucleus Accumbens: A Common Target in the Comorbidity of Depression and Addiction
Le Xu, Jun Nan, Yan Lan
Frontiers in Neural Circuits (2020) Vol. 14
Open Access | Times Cited: 85
Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature
Sandra J Drozdz, Akash Goel, Matthew W McGarr, et al.
Journal of Pain Research (2022) Vol. Volume 15, pp. 1691-1706
Open Access | Times Cited: 58
Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence‐based prediction, expert evaluation, clinical corroboration and mechanism of action analyses
Zhenxiang Gao, Theresa Winhusen, Maria P. Gorenflo, et al.
Addiction (2023) Vol. 118, Iss. 7, pp. 1307-1319
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top